Navigation Links
AEterna Zentaris Announces Appointment of Prof. Jurgen Engel, Ph.D. as New President and CEO
Date:8/12/2008

QUEBEC CITY, Aug. 12 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on endocrinology and oncology, announced today the appointment of Prof. Jurgen Engel, Ph.D. as its new President and CEO, effective as of September 1, 2008. Prof. Engel is currently Executive Vice President and Chief Scientific Officer of AEterna Zentaris. He succeeds Juergen Ernst, who had been acting as Interim President and CEO since April 2008. Mr. Ernst, current Chairman at AEterna Zentaris, will become Executive Chairman as of September 1, 2008.

"As a seasoned executive for many years at AEterna Zentaris, Prof. Engel has gained a deep knowledge of the Company's activities at all levels. We feel that his extensive expertise in drug development and commercialization as well as in strategic partnerships, make him the ideal person to lead the Company," said Mr. Ernst.

Prof. Engel added, "I am thrilled with this new challenge and will continue to dedicate all efforts to the successful development of our deep pipeline, especially the ongoing pivotal Phase 3 program in benign prostatic hyperplasia with our lead compound, cetrorelix."

Prof. Engel has been Chief Executive Officer of Zentaris AG since the beginning of 2001. Before joining AEterna Zentaris in December 2002, he was in charge of all R&D activities at ASTA Medica AG where he supervised more than 700 scientists and clinical professionals.

Prof. Engel holds a doctorate degree in organic chemistry from the Technical University of Braunschweig and an academic degree in pharmaceutical science from the University of Regensburg where he is an adjunct full professor at its School of Pharmacy. He is also Honorary Professor at
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AEterna Zentaris to Announce Second Quarter 2008 Financial and Operating Results on August 12, 2008
2. AEterna Zentaris Sells Quebec City Building for $7.1 million
3. AEterna Zentaris to Present at Upcoming Rodman & Renshaw Global Healthcare Conference and AUA Annual Meeting
4. AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal
5. AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results
6. AEterna Zentaris to Announce First Quarter 2008 Financial and Operating Results and Hold Annual Shareholder Meeting on May 7, 2008
7. AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan
8. AEterna Zentaris Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia
9. AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia
10. AEterna Zentaris Announces Changes to its Management Team
11. AEterna Zentaris and Paladin Labs Complete Sale and Purchase of Miltefosine Rights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... MN (PRWEB) April 24, 2015 Ralco ... with Advanced Birthright Nutrition® (ABN) for the exclusive worldwide ... Cup. The new technology is a new in-line milk ... producers by allowing them to move supplementation milk cups ... , “This technology lets producers get Birthright™ ...
(Date:4/23/2015)... Mount Dora, Florida (PRWEB) April 23, 2015 ... announced that it intends to conduct a groundbreaking ... can begin to be reversed in as little ... researchers—using the science of metabolic and nutritional medicine—will ... conditions that cripple and destroy our aging brain. ...
(Date:4/23/2015)... 2015 BioTE Medical President and Founder ... Live Happier - Avoiding Over-Medication through Natural Hormone Balance" ... Group Conference at JW Marriott / Ritz Carlton Grande ... Healthier Live Happier, is a welcomed response to many ... for a higher quality of life thanks to bio-identical ...
(Date:4/23/2015)... 23, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... first quarter 2015 results before the Nasdaq market opens ... a live conference call and webcast to discuss its financial ... 30, 2015 at 8:00 a.m. Eastern Time (5:00 a.m. ... conference call by dialing 866-952-1906 (US) or 785-424-1825 (International) ...
Breaking Biology Technology:Ralco Acquires License to Birthright™ Moveable Milk Cup 2New Study Looks to Reverse Alzheimer’s Disease 2New Study Looks to Reverse Alzheimer’s Disease 3Release and Book Signing of BioTE Medical President Gary Donovitz M.D. 'Age Healthier Live Happier' at Age Management Medicine Group (AMMG) Conference 2Release and Book Signing of BioTE Medical President Gary Donovitz M.D. 'Age Healthier Live Happier' at Age Management Medicine Group (AMMG) Conference 3Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2015 Results 2
... , NEW YORK, Dec. 8 ... report is available in its catalogue: , ... , http://www.reportlinker.com/p0164353/Biotechnology-Instrumentation---International-Market-Trends.html , Demand for ... the pharmaceutical industry, proteomics, genomics, functional genomics and ...
... Dec. 8 Vivakor, Inc. (OTC Bulletin Board: VIVK) today ... 1, 2009 will receive the dividend of shares of common ... Board of Directors. HealthAmerica is a private Nevada corporation of ... on the record date. The distribution date will be December ...
... , ROTTERDAM, The ... on reducing prostate cancer,mortality has been given a boost with ... Cancer (ERSPC). This shows the true impact to,be far higher ... Preliminary ERSPC findings* showed that screening reduced prostate ...
Cached Biology Technology:Reportlinker Adds Biotechnology Instrumentation - International Market Trends 2Reportlinker Adds Biotechnology Instrumentation - International Market Trends 3Reportlinker Adds Biotechnology Instrumentation - International Market Trends 4Reportlinker Adds Biotechnology Instrumentation - International Market Trends 5Reportlinker Adds Biotechnology Instrumentation - International Market Trends 6Reportlinker Adds Biotechnology Instrumentation - International Market Trends 7Vivakor Announces Mechanics of Dividend Distribution 2Vivakor Announces Mechanics of Dividend Distribution 3Boost for Prostate Cancer Screening - Report Shows Mortality Reduction as High as 31% 2
(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ... Competitive Profiles - NEC" report to their offering. ... will continue to supply a range of IT security ... company focus on the development of a Big Data ... in the Asia-Pacific region is ...
(Date:4/6/2015)... OXFORD, Conn. , Apr. 6, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... it has filed provisional patent 62/143028 for ... CLOSE-PROXIMITY COMMUNICATIONS AND ENERGY TRANSFER  NXT-ID introduces ... wireless payments. This patent surrounds the use of ...
(Date:4/2/2015)... 2015 According to preliminary estimates ... somewhat higher than 125 MSEK. This exceeds the guidance ... that revenues for Q1 2015 would be in line ... Q4 2014. The operating result for the first quarter ... interim report will as previously communicated be published on ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4Fingerprint Cards Revises Revenues for Q1 2015 2
... working to find out whether energy from trees can ... fires. What they learn also could raise ... the nation,s borders to detect potential threats such as ... predicts and tracks fires with a variety of tools, ...
... regarded as the first organisms that had fingers and ... that this is wrong. Using medical x-rays, they ... Panderichthys, the transitional animal, which indicates that rudimentary fingers ... fish ancestors evolved into the first four-legged animals, tetrapods, ...
... gene involved in vitamin D metabolism and skin cancer. Published ... a peer-reviewed journal of the American Cancer Society, the study ... gene, called BsmI, may be at an increased risk of ... the body has significant protective effects against the development of ...
Cached Biology News:MIT: Preventing forest fires with tree power 2Primordial fish had rudimentary fingers 2Variant of vitamin D receptor gene linked to melanoma risk 2
... Services is a microarray ... industrial and academic researchers. We ... of Agilent, and we provide ... Agilent catalogue arrays. Gene ...
Immunogen GST fusion protein corresponding to full-length rat JNK3/ SAPK1b. Quality Assurance Routinely evaluated by immunoblot. Stability 2 years at -20°C from date of shipment GenBank A...
... post-translational modification that plays an important ... regulation, inflammation, cell-to-cell adhesion, and cell ... lectin based Glycoprotein Isolation Kits, Concanavalin ... (WGA), that allow isolation of glycoproteins ...
... series of laser scanners is the starting ... solution. ,Gene expression analysis, SNP (Single ... essential to the advancement of research in ... novel microarray formats and sizes. These arrays ...
Biology Products: